This presentation examines the most current epidemiologic data on HIV infection in the United States, including an overview of persons at highest risk, the most recent CDC data on incidence and prevalence (including geographic, sex, ethnic, and transmission variations), and the impacts of recent advances in prevention on HIV infection rates globally. Applicable pathophysiology of HIV infection will be reviewed. Evidence-based content will be provided regarding: 1) Safe prescribing of oral and injectable FDA-approved pharmacologic agents used for pre-exposure prophylaxis (PrEP); 2) Appropriate long- and short-term PrEP treatment plans, including the 2-1-1 method for PrEP; 3) Proper implementation of CDC algorithms for preventing HIV through post-exposure prophylaxis using pharmacologic methods; 4) Clinical interpretation of CD4 counts and HIV RNA levels (viral load) and the significance undetectable viral loads in the elimination of risk of sexual transmission; and 5) The responsibility of nurse practitioners in leading future scholarship and clinical practice initiatives aimed at preventing HIV infection and reducing health disparities in vulnerable populations.

Social media use among children and adolescents is nearly universal, with many teens reporting that they are online almost constantly. While these platforms can offer social connection and entertainment, they are also linked to increased rates of anxiety, depression, sleep disruption, and suicidal ideation. For vulnerable youth, including those identifying as LGBTQ+ or from historically underserved communities, the mental health impact is often more severe. This session equips nurse practitioners with practical tools to address the influence of social media on pediatric mental health. Attendees will review current research and clinical guidelines, learn to implement evidence-based screening tools such as the PHQ-9, GAD-7, and SCARED, and explore how to set collaborative, developmentally appropriate boundaries with patients. Strategies for supporting sleep hygiene and engaging caregivers in meaningful ways will also be discussed. The session emphasizes empathy, cultural sensitivity, and realistic interventions that can be implemented across outpatient, primary care, and mental health settings. Participants will leave with ready-to-use approaches that support the emotional well-being of the children and adolescents they serve.

As the fields of pharmacogenetics and functional medicine continue to grow, nurse practitioners are uniquely positioned to lead the transformation toward personalized, root-cause-focused care. This session will explore how pharmacogenetic testing can be practically integrated into a functional medicine approach to optimize medication therapy, reduce adverse drug reactions, and enhance patient outcomes. Using real-world case studies and clinical frameworks, participants will gain tools to interpret genetic variations, tailor pharmacologic and non-pharmacologic interventions, and support patients with complex, chronic conditions in a more individualized way. This session bridges cutting-edge science with holistic care principles, empowering NPs to practice precision medicine at the primary care level.

Despite being preventable and curable, tuberculosis remains the world’s deadliest infectious disease, but it’s still often overlooked in U.S. clinical practice. This session offers a dynamic refresher on TB for nurse practitioners, covering key aspects of epidemiology, transmission, pathophysiology, and clinical presentation. We’ll break down the essential components of a TB workup, including laboratory diagnostics and radiographic manifestations of both pulmonary and extrapulmonary TB. Beyond the clinical, we’ll confront the deep-rooted stigma that still surrounds TB and explore how advocacy, trauma-informed care, and global health perspectives can drive more compassionate, effective practice. Whether you’re in primary care, acute care, or specialty settings, this session will equip you to recognize and respond to TB with clarity, urgency, and humanity.

Breast cancer screening continues to evolve, with recent updates from leading organizations such as the USPSTF, ACS, and ACOG impacting clinical decision-making. This presentation is designed to enhance participant competence and confidence in applying the latest evidence-based breast cancer screening guidelines across diverse patient populations. Through this expert-led presentation and clinical case discussions, attendees will gain knowledge acquisition, risk stratification, clinical application, and patient communication related to breast cancer screening. By the conclusion of the conference, participants will accurately identify key updates in national guidelines, differentiate between screening modalities, and apply validated risk assessment tools in clinical cases. Emphasis will be placed on adapting recommendations for diverse populations and engaging patients in shared decision-making. This presentation empowers nurse practitioners to lead practice transformation through evidence-based screening, improving early detection and outcomes for patients at risk of breast cancer.

Ear, nose and throat complaints are very common presentations in primary care practices, making up for roughly 10% of all complaints. These commonly include ear pain, hearing loss, vertigo, allergies, and skin lesions. Primary care NPs should be able to diagnose and manage many of these problems. This presentation will focus on managing chronic and acute primary care ENT complaints including ear pain, tinnitus, vertigo, allergies, and sinusitis. This presentation will assist NPs in improving assessment skills and determine when imaging is necessary and how to use subjective and objective patient information to increase diagnostic accuracy for improved patient treatment. It can reduce unnecessary referrals to subspecialty. The presentation will use evidence-based treatment options and incorporate case studies applicable to primary care and urgent care settings.

This presentation provides a practical, evidence-based introduction to wound care for novice nurse practitioners across all settings. Participants will learn how to recognize and differentiate common wound types, including pressure injuries, venous ulcers, diabetic foot ulcers, and surgical wounds. Emphasis will be placed on conducting a comprehensive wound assessment, including documentation of size, depth, tissue type, drainage, and signs of infection, to guide clinical decision-making. The session also reviews current best practices in wound management, including the selection of appropriate dressings, cleansing techniques, and strategies to promote healing and prevent complications. Through real-world examples and case-based discussion, attendees will gain the confidence to manage wounds effectively within their scope and know when to refer for advanced care. Designed to build foundational knowledge, this presentation equips nurse practitioners with the tools they need to deliver safe, high-quality wound care in primary, specialty, or inpatient settings.

This presentation equips primary care providers with essential knowledge and practical tools to support families of children newly diagnosed with adrenal insufficiency. Emphasis will be placed on early parent education, the development of emergency action plans, and strategies to prevent adrenal crisis during the critical initial adjustment period. Attendees will learn how to communicate complex medical information in an accessible way, reinforce caregiver confidence in crisis response, and assess family readiness using evidence-based methods such as teach-back. The session blends clinical guidance with real-world insights to strengthen provider-family partnerships and improve outcomes for pediatric patients with adrenal insufficiency.

This session will provide information regarding the identification of women and men at risk for fracture based on bone densitometry and their 10-year fracture risk using the FRAX calculation. Pharmacologic therapies will be reviewed including patient selection for first line therapies when fracture risk is high and therapies for patients at very high-risk including drug risks and benefits. Current controversies will be discussed including long-term use of bisphosphonates, adverse events including osteonecrosis of the jaw (ONJ) and atypical subtrocanteric femur fractures and drug holidays. New concerns about discontinuation of rank ligand inhibitors and the rapid increase in vertebral fractures will be discussed. Treatment of patients at high risk due to therapy such as aromatase inhibitors and androgen deprivation therapy will be presented. Case studies will be used to provide real clinical scenarios.

Advanced practice registered nurses (APRNs) continue to be named as defendants in civil malpractice litigation, with the average cost per claim costing hundreds of thousands of dollars (Nurses Service Organization [NSO], 2022). The rationale for this is multiplicit; but claims involving wrongful death remain the most common malpractice claims against APRNs (NSO, 2022). Despite increased risk, APRN education is largely absent of topics on issues surrounding malpractice (Sweeney, LeMahieu, & Fryer, 2017). This presentation dissects the anatomy and regulatory threshold of necessity in malpractice lawsuits, describing requisite elements for a plaintiff to file litigation against an APRN. An overview of the most recent data regarding APRN malpractice litigation will be scrutinized. A variety of real malpractice cases against APRNs will be closely explored and analyzed. Applying events and causal factor analysis (American Society for Quality, 2022), strategies will be provided that APRNs can directly apply in their clinical practice to lessen their risk for malpractice liability and negligence. Specific recommendations related to maintaining focus on scope of practice boundaries, performing and documenting pertinent physical examination findings, developing, documenting, and evaluating plans of care in primary and acute care settings, and applying concepts related to malpractice insurance policies will be emphasized.

COPD is the 3rd leading cause of death in the COPD is the United States with 90% of deaths occurring in low- and middle-income countries. COPD equates to $49.4 billion in health care costs annually and is the number one reason for hospital admissions in the world. Globally, approximately 3 million deaths annually from COPD. Yet, guideline-based care for COPD only occurs in less than 40% of patients with COPD. The Global Initiative for Chronic Lung Disease (GOLD) guidelines were developed in 1998, with the first report issued in 2001, with the goal to produce recommendations for the management of COPD, based on latest guidelines. Managing patients with COPD patients in a busy primary care practice is complex. The presentation will utilize the 2026 GOLD guidelines as well as case studies to provide an update to the NP in primary care with a particular focus on diagnosis and treatment, pharmacologic management, and when to refer or change treatment course. Guideline-based care is key to improving the lives of patients with COPD, as well as impacting their morbidity and mortality.

This session explores the far-reaching and often underestimated effects of the COVID-19 pandemic on child health. While early narratives suggested minimal pediatric impact, emerging data revealed significant physical, developmental, and mental health sequelae—including long COVID, myocarditis, and increased behavioral health crises. This session highlights findings from a newly released interprofessional textbook authored by leading national experts that examines these impacts across the pediatric care continuum: primary care, acute and specialty settings, telehealth, and institutional environments. Participants will gain insight into trauma-informed, holistic approaches to address the pandemic’s ripple effects—ranging from reduced immunization rates and disrupted developmental milestones to rising abuse and neglect concerns. The session also addresses the role of disinformation, digital engagement, and the collapse of social safety nets in shaping children’s health. Designed for nurse practitioners, this session offers practical frameworks and evidence-based strategies for supporting resilience, recovery, and innovation in child health post-COVID.

Benign prostatic hypertrophy (BPH) is a pathologic diagnosis that refers to the proliferation of smooth muscle and epithelial cells within the prostate. The prevalence and the severity of lower urinary tract symptoms (LUTS) in the aging male can be progressive and have a profound impact on an individual's quality of life. In the management of bothersome LUTs, it is important that Nurse Practitioners (NPs) recognize complex dynamics of the bladder, bladder neck, prostate, and urethra, medical therapies include alpha-blocker therapy as initial therapy, PDE5 inhibitors, as well as 5-alpha reductase inhibitors, either as single agent or combination therapy. When these therapies are no longer effective, evidence- based surgical management to treat male lower urinary tract symptoms secondary to BPH with bladder outlet obstruction (BOO) is required. New technologies include bipolar transurethral resection of the prostate (TURP), aqua ablation, robotic simple prostatectomy, and holmium laser enucleation of the prostate (HoLEP).

The number of Americans with some combination of disease, chronic illness, functional limitation, cognitive disability and/or frailty is becoming more prevalent. Management of chronic disease coupled with individualized patient-centered care goals is paramount in the reduction of hospitalizations and emergency department visits in communities. Numerous comorbidities may result in prescribing multiple medications. For the nurse practitioner (NP), an integrated preventive approach to disease management principles and individualized care goals of patients and families is essential. This shared decision-making establishes the basis for optimization of medication management to reach each patient’s goals. By attending this presentation, NP’s can conquer polypharmacy, reduce rehospitalizations, emergency room visits and enhance the lives of their communities. This presentation will explore pharmaceutical clinical guidelines and how best to optimize their effectiveness. Challenges and opportunities to address polypharmacy with the goal of deprescribing will be discussed with the goal of enhancing the lives of adults.

Sepsis remains a leading cause of mortality and healthcare burden in acute and critical care settings. With ongoing updates to clinical guidelines, nurse practitioners must stay current with evolving definitions, hemodynamic strategies, and stewardship practices. This session will highlight key updates in sepsis care as of 2026, including revised definitions and diagnostic criteria for sepsis and septic shock based on the latest clinical consensus. Attendees will apply updated guidelines for initial fluid resuscitation and the titration of two commonly used vasopressors, with emphasis on early identification and timely intervention. In addition, the session will explore emerging trends in antimicrobial stewardship, focusing on evidence-based strategies to reduce unnecessary antibiotic use without compromising patient outcomes. A special focus will be placed on one diagnostic tool that supports judicious antimicrobial use in sepsis. Through interactive discussion and real-world clinical examples, participants will leave with practical tools to enhance patient safety and align with current standards of care.

The United States and many countries worldwide are experiencing outbreaks of vaccine-preventable diseases due to decreased vaccination rates. Measles was considered eradicated in the US in 2000, yet in 2025 measles has spread nationwide with 1267 cases in the first six months of 2025, and three deaths from measles. Pertussis cases in 2024 were six times the cases in 2023, with more than 35,000 documented cases of pertussis in 2024. This presentation will review current vaccination rates in the US and worldwide, as well as current outbreaks of vaccine-preventable diseases in the US and abroad. Providers are challenged with competing sources of information, with variable reliability. Accurate sources of current vaccine information and recommendations will be discussed, as well as controversies regarding immunizations and challenges for providers working with families making immunization decisions.

Microhematuria is one of the most common urologic diagnoses, accounting for over 20% of urologic referrals. Prevalence in screening studies among healthy individuals range from 2.45% to 31.1%. The causes of microhematuria can range from entities such as urolithiasis, benign prostatic hyperplasia, and infection to more potential malignant causes such as cancer of the bladder, upper urinary tracts, and kidneys. Microhematuria can also be confused with gynecological sources of bleeding, myoglobinuria or pigmentation of the urine from ingestions of certain foods and drugs. Practice pattern assessment studies have revealed that less than 50% of patients with microhematuria are referred by their primary care provider to a Urological specialist for evaluation. Delays in diagnosis can lead to missing serious entities, including malignancy. Therefore, following clear, evidence-based guidelines for evaluation of microhematuria are of paramount importance. The American Urological Association (AUA) together with the Society of Urodynamics and Female Urology (SUFU) developed guidelines to help not only identify important urologic conditions that require prompt evaluation and treatment but also to help limit over-treatment and contain costs for those patients who are deemed a low risk for malignancy. These guidelines were updated in 2025 based on the latest evidence available.

Background and Significance to Nurse Practitioners: Heritable connective tissue disorders (CTDs) (e.g., Marfan syndrome, Loeys-Dietz syndrome, and Vascular Ehlers-Danlos syndrome) are a diverse group of genetic disorders (inherited and spontaneous) that compromise aortic tissue. These heritable aortic disorders are linked to an increased risk of developing aortic disease and associated clinical complications such as aortic aneurysm, dissection, and rupture. While these patients often receive treatment from high-volume aortic centers, it is essential that Advanced Practice Providers (APPs) can identify and assess patients with CTDs in order to provide timely referrals and assist with long-term surveillance imaging monitoring. Purpose/Objective: An overview of common heritable CTDs will be provided, including the physical characteristics of Marfan, Loeys-Dietz, and Vascular Ehlers-Danlos syndromes. Online resources and diagnostic tools for Marfan syndrome will be targeted to APPs. Examples of?computed tomography angiography (CTA) imaging in CDT patients will demonstrate findings of aneurysm, dissection, and rupture. Additionally, the 2022 Aortic Disease Guidelines for current diameter-based thresholds of repair and surveillance monitoring in CTD patients will be highlighted. Lastly, current research regarding CTD patients and pharmacological medications will be emphasized to show those with protective properties and those that may increase the risk of aortic dissection.

The Office of Advanced Practice (OAP) at the University of Colorado School of Medicine and University of Colorado Hospital has evolved into a strategic entity bridging academic and clinical priorities, workforce engagement, and institutional growth. As the Nurse Practitioner (NP) workforce expands, organizations must build structured systems that support leadership development, career advancement, and long-term workforce sustainability. Functioning as an Office of WE, the OAP fosters alignment between school and hospital leadership to promote NP engagement, operational efficiency, and professional development. Through a dual-reporting framework, the OAP has created a model that enhances retention, strengthens institutional alignment, and supports a culture in which NPs contribute meaningfully to quality, patient safety, and system-wide innovation. A growing internal pipeline, with RNs returning to school and transitioning into NP roles within the organization, further reinforces this model. This presentation will explore the OAP’s evolution, its strategic design, and its impact on NP workforce growth, leadership integration, and organizational resilience.

The pediatric mental health crisis continues to escalate, with trauma at the root of many behavioral and developmental concerns presenting in primary care. Nurse practitioners are on the front lines—often the first to witness the impact of trauma on children and families. This session provides nurse practitioners with the knowledge and tools needed to confidently recognize, respond to, and integrate trauma-informed care within their clinical practice. Grounded in developmental science and practical application, this session moves beyond theory to offer realistic, evidence-based strategies that can be implemented immediately, even in fast-paced primary care settings. Participants will explore trauma’s physiological and behavioral manifestations, learn how to reframe "difficult" behaviors through a trauma-informed lens, and develop communication techniques that build safety, trust, and resilience in pediatric patients. The presentation empowers nurse practitioners to stay within their scope while expanding their impact, collaborating with behavioral health teams, schools, and families. It also addresses opportunities to pursue additional certifications and deepen expertise in trauma-informed practice. Whether new to trauma-informed care or looking to sharpen your skills, this session equips you to lead healing-centered care that transforms outcomes for the children and families you serve.

This presentation is designed to increase awareness and knowledge concerning women and CVD. Worldwide about 1 in 16 women age 20 and older (6.2%) have coronary heart disease with 8.94 million women affected worldwide making CVD is the #1 Killer of women. Recognition of heart Dx is complex with many female-only risk factors impacting future CV disease. Unique female risks include: preterm delivery (a 2 fold increase in CVD), Preeclampsia /HELLP (1.8 o 2.5-fold increase for future CVD and 4-fold increase in Heart failure), placental syndromes (1.51 times greater of arrhythmias), Gestational Diabetes (Doubles DM risk and a 1.5 x greater risk of CVD), Polycystic ovarian syndrome (independent risk factor for premature CAD), and any menstrual irregularities have a 50% increased risk of CVD. Women have more CV disease, receive less treatment, less medications, less rehabilitation, less education, die sooner. NPs can make a difference in these women’s lives. The OB/GYN history is easy to obtain and all abnormal events during labor and delivery are well-known decades before CVD develops. NP’s can provide the education and support to maximize cardiovascular support including medications, patient education, and lifestyle management.

Dizziness is a frequent yet complex complaint in the emergency department (ED), representing 2–4% of annual visits. Nurse practitioners play a critical role in the frontline evaluation and management of these patients. This session offers a practical, case-based approach to assessing acute dizziness and vertigo in the ED, with an emphasis on focused history-taking, targeted neurological examination, and bedside maneuvers such as the HINTS and Dix-Hallpike tests. Attendees will review the current clinical guidelines, explore clinical-decision pathways that support safe and accurate decision-making, and identify strategies to reduce unnecessary imaging. Common pearls and pitfalls will also be discussed to enhance diagnostic confidence, improve patient safety, and support high-quality NP practice in emergency care settings.

This presentation will review the key care considerations when deciding to initiate long-acting and mealtime insulin therapy in ambulatory care. After a review of the pharmacodynamics of the most commonly prescribed insulin categories, the American Diabetes Association Algorithm for insulin therapy initiation and titration will be discussed in detail. With that foundation, the presentation will review patient examples of the successful initiation of long-acting and mealtime insulin therapy, using serial glucose results to illustrate the impact of appropriate dose selection. Clinical pearls and key elements of patient education and support will be emphasized. Participants will leave with greater confidence to manage insulin therapy when they return to clinic.

While only 4% of individuals experience bipolar disorder in their lifetime, over 80% of these individuals live with “serious impairment” due to their symptoms. Bipolar II disorder is underrecognized and undertreated by primary care clinicians as initially reported symptoms are depressive in nature and more subtle than bipolar I disorder. Though often qualified as a less serious form of the disorder, bipolar II disorder is equally detrimental to overall function and comparable in terms of an elevated risk of suicide. Symptom overlap with diagnoses such as major depression, ADHD, anxiety, and personality disorders often leads to misdiagnosis. This presentation will discuss how clinicians can evaluate patients presenting with depressive symptoms to determine if a diagnosis of bipolar II disorder is most accurate based on clinical diagnostic criteria. Recommended screening for common medical and psychiatric comorbidities will also be outlined and the most up to evidence-based treatment guidelines reviewed.

On October 23, 2024, the Centers for Disease Control and Prevention (CDC) recommend a major change in its guidelines for pneumococcal vaccination in adults. The agency lowered the recommended age of vaccination from 65 to 50, citing the rationale for the change to be based in the opportunity to protect adults from pneumococcal disease when risk of infection substantially increases. This presentation discusses recent epidemiological and clinical data regarding pneumococcal disease (with a focus on Streptococcus pneumoniae community-acquired pneumonia) in adults, the current CDC recommendations for pneumococcal vaccination in adults, adverse events and contraindications associated with the vaccines, and the role of nurse practitioners, nurses, and other clinicians in advocating for pneumococcal vaccination in adults to promote public health.

Body contouring after massive weight loss is often viewed as cosmetic, yet for many patients, it is a critical final step in their obesity treatment journey. This presentation will examine the role of reconstructive surgery in enhancing function, hygiene, and quality of life for individuals who have undergone significant weight loss through bariatric surgery or lifestyle modifications. Attendees will learn about the most common procedures, including panniculectomy, abdominoplasty, brachioplasty, and lower body lifts, and how to assess candidacy based on clinical indicators and patient goals. The session will also address the importance of thorough documentation and medical necessity criteria when seeking insurance coverage, including preoperative requirements, symptom duration, and the use of appropriate photographic support. Drawing on nearly a decade of clinical experience in plastic and reconstructive surgery, the presenter will share case examples, evidence-based guidelines, and strategies for interdisciplinary care. This presentation is ideal for nurse practitioners and advanced practice providers who care for patients navigating the post-weight loss phase of treatment and are seeking tools to support optimal outcomes and access to necessary surgical care.

The American Heart Association’s clinical guidelines continue to shape cardiovascular care across diverse practice settings. This 60-minute session explores recent AHA updates through the lens of the latest scientific evidence and clinical trial data. Priority will be given to the management of patients with acute coronary syndromes and the latest Emergency Cardiovascular Care Guidelines released in 2025. Emphasizing practical application, the session highlights how and why recommendations have evolved, dispels common misconceptions, and examines the implications for frontline providers. Using real-world case examples, participants will leave equipped with tools to translate guideline updates into actionable clinical decisions. This session is ideal for nurse practitioners and other advanced clinicians committed to evidence-based cardiovascular care.

Thyroid disease is common, affecting about 12% of the US population, approximately 20 million Americans have some form of thyroid disease. Hypothyroid disease impacts approximately 5% of Americans over the age of 12 years old. This session will give the primary care provider a review of the prevalence, epidemiology, genetics, assessment, diagnosis, and treatment of hypothyroidism. The importance of early identification and surveillance is demonstrated on the long-term outcomes of untreated disease. Patients may present with subtle symptoms, and clinicians must be astute to assess the signs and symptoms to make the correct diagnosis. This session will cover the tools needed to be successful and will present interesting, real-life case studies to illustrate diagnosis and treatment for patients with hypothyroidism.

Pediatric visits to urgent care or after-hours clinics have been increasing with 28.4% of children and adolescents having at least one urgent care visit per year, according to the Centers for Disease Control. Providers who care for children in urgent care may or may not have a complete past medical history. Additionally, parents may present with an assumption that a prescription is needed for their ill child. It is critical that providers working in urgent care follow guidelines for managing common presenting problems. This presentation will provide a fast-paced review of common presenting diagnosis seen in pediatric urgent care and guidelines for management.

Lynch Syndrome is a heredity form of colon cancer and includes other cancers which may present as a result of an autosomal dominate genetic defect. DNA replications error is present in individuals with Lynch Syndrome, which presents most often as colon cancer. Knowledge of cancer guidelines, and careful history taking can enable prevention, early diagnosis and treatment of a potentially life threating cancer. New treatments with immunotherapeutic drugs have enabled patients to have cancers eliminated, who would have had poor prognoses. Discussion of the use of immunotherapy and imaging measures to track the progress of cancers will be discussed. Ethical issues surrounding testing, emerging immunotherapeutic treatments, and reproductive issues will be discussed.

NPs are often familiar with treating patients with STEMI and nstemi which are considered Type 1 MI’s. Few are aware that there are 5 types of MI’s. We are hearing more about the Type 2 MI, explained as an imbalance in oxygen supply and demand. Many times any patient with even a slight elevation in troponin is given that diagnosis. Often no real cardiac care is given or felt to be necessary, but these patient's outcomes are worse than with Type 1 MI patients. This presentation will discuss the 5 types of MI, their diagnosis and management with a focus on Type 1 and Type 2 MI’s and review guideline-directed medical therapy for all patients diagnosed with MI.

Pertussis can be challenging to diagnose and manage in real-world practice, especially when testing is delayed or unavailable. This session equips clinicians with practical strategies for recognizing when to treat presumptively, identifying high-risk exposures, and selecting appropriate antibiotic regimens. Emphasis will be placed on evidence-based guidelines, public health updates, and protecting vulnerable and underserved populations through timely treatment and post-exposure prophylaxis.

This presentation will explore three complex clinical cases in pediatric acute and critical care, each illustrating key diagnostic and management principles. The first case will examine varied clinical presentations and underlying causes of hyperglycemia in pediatric patients, emphasizing the importance of context-specific assessment and intervention. The second case will address a child presenting with acute hypoxia, underscoring the necessity of maintaining a broad differential diagnosis and systematically narrowing possibilities through clinical reasoning and diagnostic testing. The final case will focus on emerging and innovative therapies in the treatment of pediatric sepsis, highlighting evolving evidence and their potential impact on outcomes in critically ill children.

Parkinson’s disease (PD) is a common neurodegenerative disorder and a growing concern in aging populations. Early recognition and effective management of Parkinson’s remain challenging especially in primary care and non-neurology settings where NPs can make a difference. This session equips NPs with essential knowledge to identify early signs of PD, facilitate timely diagnosis, manage motor and non-motor symptoms, and navigate complex medication regimens. The speaker, an Edmond J. Safra Parkinson’s Educator fellowship participant, will highlight the non-motor presentations which often precede motor symptoms. The session will also address common care challenges including medication timing, fall and aspiration prevention, caregiver burden, and care coordination with specialty services. Through case studies, participants will explore a team-based approach to managing PD across the disease trajectory using evidence-based guidelines. Patient and professional resources from the Parkinson’s Foundation and American Academy of Neurology will be shared. This presentation is designed for nurse practitioners in primary care, acute care, geriatrics, neurology, long-term care, and home-based settings. Participants will leave with actionable strategies, clinical pearls, and tools to improve quality of life for individuals living with Parkinson’s and their care partners.

Vertigo is a common and diagnostically challenging symptom, accounting for approximately 2.5–5% of all ED visits. Differentiating between peripheral and central causes of vertigo is critical, as missing a central etiology such as cerebellar stroke can result in devastating outcomes. Nurse practitioners play a key role in the initial triage, assessment, and management of patients presenting with vertigo. Accurate bedside diagnosis of vertigo remains an area of clinical uncertainty. Recent evidence highlights the utility of targeted physical examination tools, such as the HINTS (Head Impulse, Nystagmus, Test of Skew) exam, which can outperform early imaging in identifying posterior circulation strokes. Empowering NPs with these tools enhances patient safety and reduces diagnostic delays. This 60-minute podium presentation will equip NPs with a comprehensive, evidence-based framework for differentiating central from peripheral vertigo. Topics include: Review of vestibular anatomy and pathophysiology; Clinical characteristics of common peripheral and central vertigo syndromes; Red flag symptoms; Step-by-step instruction on performing and interpreting the HINTS exam; Case scenarios illustrating key decision points; Demonstration videos of the Dix-Hallpike and Epley maneuvers. Through clinical reasoning, case studies, and practical demonstrations, this presentation will enhance the diagnostic accuracy and confidence of NPs evaluating patients with vertigo.

This one-hour session provides nurse practitioners with a concise, evidence-based approach to the assessment and management of concussion across the lifespan. The presentation covers the latest clinical guidelines on recognizing concussion symptoms, conducting a focused neurological and cognitive exam, and using standardized assessment tools such as SCAT6. Special attention is given to differentiating concussion from more serious brain injuries, managing return-to-learn and return-to-play protocols, and understanding the role of rest, activity, and symptom monitoring in recovery. Case studies will highlight real-world scenarios in primary care and sports medicine settings. This session equips NPs with the practical tools and clinical judgment needed to confidently care for patients with concussions in a variety of practice environments.

Artificial intelligence is increasingly embedded in clinical practice, transforming how nurse practitioners approach diagnosis, treatment planning, and patient communication. This session explores the evolving role of artificial intelligence in healthcare through the lens of clinical evidence, ethical principles, and professional accountability. Participants will begin by analyzing recent studies that demonstrate how artificial intelligence can enhance diagnostic accuracy, support mental health interventions, and improve decision-making across clinical settings. Building on that foundation, the session applies key ethical, legal, and professional frameworks to guide the responsible use of artificial intelligence in practice. Guidance from the World Health Organization, American Nurses Association, and American Medical Association will be used to examine concerns such as algorithmic bias, transparency, liability, and patient autonomy. The final segment focuses on practical strategies for nurse practitioners to implement artificial intelligence safely and ethically. Topics include informed consent, data privacy, explainability, and clinical oversight. Designed for nurse practitioners in all specialties, this session emphasizes practical insights to support the ethical integration of artificial intelligence. Attendees will leave with tools to evaluate technology, apply clinical judgment, and maintain patient trust as they navigate the opportunities and challenges of artificial intelligence in healthcare.

GLP-1s Unlocked: From Plateau to Progress offers a practical, in-depth exploration of the evolving role of GLP-1 receptor agonists in managing obesity and overweight. Tailored for advanced practice nurses, this session will examine how to select the most appropriate agent by balancing mechanism of action, clinical efficacy, and real-world considerations such as access and cost. Participants will also apply best practices for titration and monitoring through case-based discussions and evidence-informed strategies. Attendees will leave empowered to optimize GLP-1 therapy and support patients in overcoming weight loss plateaus to achieve sustainable progress.

Provide clinicians an overview and update in Multiple Sclerosis from medical history and neuro exam to diagnosis and management, with a review of the current treatment landscape. This presentation will include a de-identified real-world patient case to help tie in all the content covered during the presentation in a non-biased manner.

This presentation for Primary Care NPs provides a comprehensive update on dementia care. The session begins by highlighting the growing prevalence of dementia and the NP's crucial role in early detection and management. The presentation emphasizes a systematic approach to assessment, utilizing detailed history, cognitive screening tools like the Mini-Cog or MoCA, and essential lab work to rule out reversible causes. A major focus is on recent advancements in diagnostics, explaining the appropriate use of structural imaging (MRI) and the emerging frontier of blood-based biomarkers (p-tau, Aß), while positioning PET scans and CSF analysis as specialist tools. Pharmacological updates cover foundational treatments like cholinesterase inhibitors and a review of new anti-amyloid monoclonal antibodies, including their indications for early Alzheimer's, efficacy, and safety monitoring. The presentation strongly advocates for non-pharmacological strategies and robust caregiver support as the cornerstones of high-quality dementia care. The key takeaway is to integrate these updates for a comprehensive, patient-centered approach.

Adolescence is a pivotal stage for shaping lifelong health, yet it presents unique challenges related to lifestyle choices and risk behaviors. Nurse practitioners are at the forefront of guiding young people toward optimal well-being. This presentation will equip NPs with evidence-based strategies to effectively promote healthy lifestyles in their adolescent patient population, drawing upon the latest guidelines from the American Academy of Pediatrics (AAP), National Association of Pediatric Nurse Practitioners (NAPNAP), and American College of Obstetricians and Gynecologists (ACOG). We will delve into practical, patient-centered approaches, including the application of Motivational Interviewing to foster positive changes in nutrition, physical activity, and sleep hygiene. Participants will learn to skillfully screen for substance use (alcohol, tobacco, vaping, illicit drugs) and implement brief interventions or appropriate referrals. The session will also provide actionable strategies for addressing the growing concerns of adolescent overweight/obesity and recognizing early signs of disordered eating, ensuring timely and effective management. By integrating these comprehensive strategies, NPs can empower adolescents to build foundational habits for a healthier future, ultimately impacting long-term health outcomes and preventing chronic disease.

This talk will provide an update on managing high blood pressure (BP) based on the 2025 AHA/ACC Clinical Guidelines for Treatment of High BP. Emphasis will be placed on changes to real-world practice based on changing evidence and emerging therapies.

Perinatal mood and anxiety disorders (PMADs) are among the most common complications of pregnancy and postpartum, yet they often go unrecognized and undertreated. Identifying and managing these conditions can be complex, as clinicians must consider the mental health needs of the birthing individual alongside the safety of the fetus and newborn. This presentation will examine the unique physiological and psychological challenges of the perinatal period and their impact on mental health. It will outline evidence-based approaches for screening and identifying individuals at risk for PMADs. Both pharmacologic and non-pharmacologic treatment strategies will be discussed, with a focus on clinical decision-making and individualized care. Special attention will be given to recent advancements in pharmacotherapy for postpartum depression, including newly approved medications and emerging treatment guidelines.

Alcohol withdrawal management is a critical aspect of care for patients with alcohol dependence/alcohol use disorder and requires timely and effective interventions to prevent complications. This presentation aims to improve patient outcomes, reduce complications, decrease length of stay, and enhance overall care quality. A key component of optimized alcohol withdrawal management is the integration of one of the various assessment tools, along with a discussion on the common challenges staff face when applying these scales to the elderly, confused, intubated, or patients with advanced liver disease. Symptom-triggered versus fixed-schedule benzodiazepine dosing protocols will be discussed based on the most common patient populations who could benefit from each of these protocols. We will also delve into alternative management options if side effects limit the use of these medications in alcohol withdrawal, along with adjunctive and emerging therapies. Lastly, we will discuss structured education on symptom assessment, risk stratification, and evidence-based medication titration for all staff to enable them to objectively assess withdrawal severity and risk factors.

This presentation will review the fundamentals of phenotyping patients with asthma and COPD. It will explore various biomarkers and diagnostic tests used to phenotype patients with asthma and COPD and discuss the implications of phenotyping these patients in the primary care setting. Learners will be able to identify available testing to better phenotype patients with asthma and COPD in order to recommend emerging biologic therapies for these patients.

Acute hepatitis is characterized by the rapid onset of liver inflammation, often presenting with jaundice, elevated liver enzymes, and systemic symptoms, and sometimes it can be an incidental finding. Timely and accurate diagnosis is crucial for guiding treatment and preventing complications, including liver failure. The acute hepatitis workup panel is a standardized set of laboratory tests used to identify the etiology of liver injury. Acute hepatitis workup examines the components of the acute hepatitis panel, including serologic markers for different viral hepatitis, and, in some cases, additional tests for Epstein-Barr virus (EBV), cytomegalovirus (CMV), Herpes Simplex virus (HSV), autoimmune hepatitis markers, and toxic/metabolic causes. The clinical yield of each component is analyzed based on published data and diagnostic algorithms. The panel effectively differentiates viral hepatitis from other causes of liver dysfunction. Expanded panels may identify alternative etiologies in seronegative cases and appropriate referrals to experts. However, overuse or misinterpretation can lead to unnecessary testing or delays in diagnosis. The acute hepatitis workup panel is a valuable diagnostic tool if used in the appropriate clinical context. It is important that the acute hepatitis panel have to integrates with patient history, risk factors, and physical findings to enhance diagnostic accuracy.

Thyroid storm is a rare but life-threatening endocrine emergency requiring rapid recognition and prompt intervention to prevent multisystem organ failure and death. This 60-minute podium presentation equips nurse practitioners—especially those in acute and critical care—with essential skills for identifying and managing thyroid storm. The session will begin with a review of pathophysiology and risk factors, including surgery, infection, and medication nonadherence. Participants will learn to distinguish thyroid storm from other hyperthyroid states using validated diagnostic tools such as the Burch-Wartofsky Point Scale. A structured, step-by-step emergency management approach using the Airway, Breathing, Circulation (ABC) framework will be presented. Evidence-based pharmacologic strategies will be covered in detail, including appropriate use of antithyroid agents, beta-blockers, corticosteroids, and iodine solutions. Supportive therapies and the role of plasmapheresis for refractory cases will also be discussed. Case studies will be used to apply concepts in clinical practice. The session will conclude with guidance on long-term care, medication tapering, endocrine referral, and patient education. This session offers pharmacology contact hours and is ideal for NPs in hospital, emergency, or ICU settings seeking to strengthen their endocrine crisis management competencies.

Atrial fibrillation (AF) is a common cardiac arrhythmia seen in primary care and can be intimidating to experienced providers. This presentation explores the epidemiology, screening, and risk assessment of AF, as well as symptom management and stroke risk. Discussion of diagnostic testing, novel therapeutic agents, procedures, and when to refer to specialty care help clarify AF management for the primary care NP.

Eating Disorders in Clinical Practice: A 60-Minute Guide for Nurse Practitioners. This one-hour presentation provides nurse practitioners with a practical, evidence-based overview of recognizing, assessing, and managing eating disorders across the lifespan. The session will cover the spectrum of eating disorders—including anorexia nervosa, bulimia nervosa, binge eating disorder, and avoidant/restrictive food intake disorder (ARFID)—with emphasis on early identification in primary care and outpatient settings. Key topics include medical and psychiatric warning signs, screening tools such as the SCOFF questionnaire, and strategies for conducting sensitive, nonjudgmental interviews. The presentation will also outline initial management steps, medical monitoring guidelines, referral pathways, and when hospitalization is indicated. Special attention is given to the role of the NP in care coordination, patient education, and supporting long-term recovery. Through case-based discussion, participants will gain the confidence to intervene early, provide safe and compassionate care, and collaborate effectively with multidisciplinary teams.

Many patients continue to struggle with insomnia even while taking medications. Determining which drugs are truly effective, and for which populations, is often complicated by outdated practices, off-label use, and rapidly evolving evidence. As frontline providers managing sleep disturbances across the lifespan, nurse practitioners face complex decisions that demand clarity and precision. This session offers a fresh and critical examination of pharmacologic treatment for insomnia, challenging assumptions and presenting what the latest research reveals. Through case-relevant insights and a lifespan approach, attendees will examine which medications offer the greatest benefit and which may contribute to unintended harm. The presentation highlights how dual orexin receptor antagonists are reshaping insomnia care, clarifies the limited role of melatonin, and addresses the shortcomings of common prescribing patterns such as trazodone and benzodiazepines. Participants will leave with clear, evidence-based strategies for tailoring pharmacotherapy in children, adults, and older adults, including individuals with psychiatric or cognitive comorbidities. This session delivers more than an overview of current treatments. It provides nurse practitioners with the insight and confidence needed to make safe, effective, and individualized treatment decisions in one of the most nuanced areas of clinical practice.

This presentation will explore the critical aspects of diagnosing and managing cervical and coronary artery dissections, two potentially life-threatening vascular emergencies. Cervical artery dissections, including carotid and vertebral dissections, can lead to stroke and other neurological complications, while spontaneous coronary artery dissection (SCAD) presents as an acute coronary syndrome, often in younger, healthier patients. The session will cover the pathophysiology, risk factors, clinical manifestations, and diagnostic approaches for both conditions, with a focus on distinguishing between them based on presentation. Through a comprehensive review of diagnostic tools such as imaging modalities (CTA, MRA, coronary angiography) and clinical decision-making, attendees will gain a deeper understanding of how to manage these emergencies in both acute and long-term care settings. The presentation will incorporate two real-world cases from personal clinical experience, one highlighting a patient with SCAD and another with a cervical artery dissection, to offer practical insights and real-world applicability. By the end of the session, participants will be able to identify early signs of both types of dissections, understand their underlying mechanisms, and integrate evidence-based strategies for managing these vascular events, improving patient outcomes in emergency care.

This presentation will describe the current consensus of national HPV testing guidelines and the determination of risk for developing CIN3+ abnormalities of cervical tissue. HPV and cervical cancer pathophysiology will be discussed. We will also discuss recommendations for the treatment of abnormal Pap and primary HPV testing results. The participants will engage in a case study of a patient with abnormal cervical screening results and determine the appropriate management using a risk-based tool/App. Use of technology, including artificial intelligence (AI), will be discussed. Current research evidence will be presented on HPV latency and viral reactivation in immunocompromised men and women. Current recommendations for the HPV vaccine use will also be discussed.

Pulmonary hypertension (PH) is a complex, life-threatening condition often encountered in the critical care setting. Rapid identification and intervention are shown to improve outcomes. This presentation will provide advanced practice nurses with a strategic approach to the diagnosis and classification of PH by highlighting the clinical manifestations and pathophysiology of each type. Emphasis will be placed on the selection of diagnostic strategies and interpretation of laboratory, radiographic, and hemodynamic data to make the diagnosis. Evidence-based pharmacologic, ventilatory, and supportive interventions will be reviewed. Case studies will be used to illustrate concepts and allow participants to apply new knowledge in lifelike scenarios.

This presentation will focus on current guidelines for the management of lipid disorders, particularly AACE and ACC/AHA. Major guidelines will be reviewed in terms of risk stratification, primary and secondary targets, pharmacotherapy, lifestyle modification, and clinical decision making. Risk assessment will be reviewed, in terms of levels of risk, therapeutic targets, and special populations. Case studies will be used to translate guidelines into practical applications and highlight clinical pearls.

This session offers a vital exploration of ADHD in women. Moving "Beyond Diagnosis," the presentation delves into the nuanced ways ADHD manifests in females, often overlooked or misdiagnosed in clinical and community settings. Attendees will gain insights into the significant impact of ADHD across the full spectrum of a woman's life roles, including home, relationships, parenting, and career. Through case examples and practical strategies, the session will equip participants to better identify, assess, and empower women navigating the challenges of ADHD in their daily lives. Emphasis will be placed on evidence-based approaches to self-care, skill-building, psychopharmacological considerations, and fostering supportive family dynamics. This presentation aims to enhance confidence in providing comprehensive, specialized care for women with ADHD, drawing from extensive clinical and community experience.

Anxiety is the most common mental health disorder across the lifespan. The lifetime prevalence of developing an anxiety disorder in the U.S.A is approximately 33%. Some studies suggest that half of all lifetime cases begin by age 14. Anxiety and fear are a part of normal development and the human experience. However, when the anxiety becomes disruptive and impairs activities of daily living, a plethora of problems may occur. While Anxiety Disorders are very common and prevalent, the conditions are often under recognized and under treated. Nurse practitioners in primary care are usually the first health encounter for the anxious patient. Clinical expertise is required when evaluating this population to differentiate anxiety disorders from normal psychological processes or other conditions. This evidence-based presentation will focus on the identification and diagnosis of anxiety disorders across the lifespan in the primary care setting. Differential diagnosis and comorbidity will be examined and discussed. Pharmacological and non-pharmacological modalities in the management of anxiety disorders will be explained. Adverse childhood experiences, past trauma, and the lingering impact of Covid-19 will be examined as well as suicide risk and prevention. Improving resilience and mitigating risk factors to improve quality of life will be explored.

Primary care providers are often the first point of contact for pediatric patients with acute concerns—but when is it safe to treat in-office, and when should a child be urgently referred for emergency care? This session equips nurse practitioners with practical, evidence-based tools to confidently distinguish between benign and potentially life-threatening pediatric presentations. Using a case-based approach, we will explore high-risk red flags, subtle signs of deterioration, and age-specific considerations for conditions that require a higher level of care. Attendees will learn to apply clinical decision-making strategies to real-world scenarios, improving patient outcomes and reducing delays in care. Whether in a rural clinic or busy urban practice, NPs will leave better prepared to make the critical “treat or street” call when it matters most.

Pelvic Floor Dysfunction is the abnormal function of the pelvic floor muscles. The exact cause and pathophysiology are unknown. Although, researchers have proposed multiple hypotheses. The pelvic floor consists of a dynamic group of muscles and nerves that serve to support the pelvic organs, coordinate bladder and bowel functions, and sexual activity. A variety of symptoms can present across multiple domains depending on the location of the pelvic floor dysfunction. Those symptoms range from urinary incontinence, urinary frequency, bulging of the bladder or urethra into the vagina, dyspareunia, constipation, fecal incontinence, and pelvic pain. A thorough history and physical examination and multidisciplinary approach are essential to determining the cause and treatment plan. A variety of diagnostic tools to include urodynamics, cystoscopy, ultrasound, MRI, CIT, anorectal manometry, EMG, balloon expulsion, and defecography are available to aid clinicians and guide treatment. Treatment for pelvic floor dysfunction depends on the area of the pelvis affected. Treatments such as lifestyle modifications, Kegel exercises, medications, Pelvic Floor Physical Therapy, Biofeedback, Intravesical injection of botulinum toxin A, and surgery.

Interactive presentation that provides relevant information to guide knowledge and practice regarding palliative care benefits, presents guidelines for referral to palliative care, and discusses strategies for difficult conversations. A case study patient will be utilized to demonstrate concepts and guide discussion with attendees.

Acute rhinosinusitis (ARS) remains one of the most common conditions, prompting antibiotic use in adults, accounting for approximately one in five prescriptions. Chronic rhinosinusitis (CRS), meanwhile, impacts an estimated 12 million individuals worldwide, contributing significantly to patient morbidity and healthcare burden. In response to evolving evidence, the American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS) recently released an updated Clinical Practice Guideline for Adult Rhinosinusitis, revising recommendations initially published in 2015. This session will provide a comprehensive overview of the updated guideline, highlighting key changes in diagnosis, management, and treatment recommendations. Through interactive case-based discussions, participants will apply these updates to real-world clinical scenarios to enhance decision-making and optimize patient outcomes. Attendees will leave with practical strategies for incorporating guideline-based care into their clinical practice.

Servicemembers and Veterans face complex health challenges, including combat-related injuries, PTSD, and chronic diseases linked to their service. In addition, military-connect families experience unique physical and psychological health issues secondary to their servicemembers' military service. Despite the need for specialized care, no unified nursing body has provided the necessary standards, training, and advocacy. The AMVN seeks to fill this gap through a professional community that supports nurses and ensures consistency in high-quality care for this population. This presentation will provide an overview of the unique healthcare needs of Servicemembers, Veterans, and military-connected families and the need for culturally competent, Veteran centric care and the role ARNPs play in providing this care; will provide an overview of the newly created Association of Military/Veteran Nursing and how ARNPs can collaborate and share Veteran and military care expertise as well as gain clinical expertise in order to provide culturally competent care for military and Veteran populations; and will provide additional resources available to ARNPs to guide the care of Servicemembers, Veterans, and military-connected families in civilian healthcare entities.

Adrenal insufficiency is a potentially life-threatening and frequently under-recognized endocrine disorder, particularly in hospitalized patients. This session will offer a comprehensive review of adrenal physiology and delineate the pathophysiologic differences among primary, secondary, and tertiary adrenal insufficiency. Using clinical case examples and evidence-based diagnostic algorithms, participants will learn to identify both subtle and emergent presentations of adrenal insufficiency. The session will also focus on pharmacologic management, including acute adrenal crisis intervention and the initiation of appropriate cortisol replacement therapy. Special attention will be given to the acute care considerations for patients on chronic exogenous corticosteroids.

Infectious endocarditis (IE) is an infection involving the endocardial surface of the heart with nearly a 100% mortality rate if left untreated. Unfortunately, the rates of IE continue to increase due to intravenous drug use, cardiac implanted electronic devices, and comorbidities associated with an aging population. The proliferation of multidrug resistant organisms has made IE increasingly difficult to treat. It is imperative that IE is detected early and treated immediately with broad-spectrum antibiotics after blood cultures are obtained. This presentation will review the epidemiology, pathophysiology, clinical presentation, the updated 2023 Duke-International Society for Cardiovascular Infectious Disease (ISCVID) Criteria for IE (which is the new preferred diagnostic criteria for IE), in addition to the role of the Infectious Disease Society of America and European Society of Cardiology's guidelines for treatment of patients with IE.

Excessive gaming and screen time have become major contributors to a growing list of physical and psychosocial health concerns in children and adolescents. Nurse practitioners are uniquely positioned to recognize and address these issues early in primary care settings. This session will examine the physical and psychosocial effects of prolonged gaming, including postural dysfunction, repetitive strain injuries, visual disturbances, obesity, sleep deprivation, and co-morbid mental health conditions. Attendees will learn how to assess gaming related health risks during pediatric visits, recognize common related physical and psychosocial conditions, and apply practical, evidence-based strategies to guide families in creating healthier technology habits.

Spine infections represent up to 7% of all musculoskeletal infections. The presenting symptoms often are no different than those who suffer from degenerative musculoskeletal conditions resulting in delay in properly diagnosing a spine infection. This presentation explores spinal infections in older adults, addressing their unique risks, symptomatology, evidenced based treatments, and associated challenges. It highlights the significance of early detection and management in addressing the unique challenges faced by this vulnerable population.

This presentation explores the complex and evolving implications of premature birth across the lifespan, with a focus on the role of the Nurse Practitioner in delivering comprehensive, evidence-based care. Participants will examine the physiological, neurodevelopmental, and psychosocial outcomes associated with prematurity from infancy through adulthood. Emphasis will be placed on integrating developmental and family-centered care principles, evaluating long-term health trajectories, and applying current clinical guidelines to optimize outcomes. Through a systematic review of current research, APNs will enhance their competencies in managing the multifaceted needs of this growing patient population.

This presentation discusses the common presenting symptoms of anorexia in patients without low body weight and shows that they are startlingly similar to anorexia with low body weight. Through case studies, the presentation will describe the urgency and difficulty of diagnosing these patients, the barriers they face in obtaining care, and the importance of recognizing and treating cardiac, GI, and other complications of the illness. The risk of suicide (eighteen times more likely among patients with anorexia) will be discussed, along with other causes of mortality in this population. Laboratory and imaging studies necessary for those with risk of refeeding syndrome, pseudo-Bartter syndrome, and osteoporosis will also be addressed.

There have been several pulmonary pharmacotherapy updates in the last year with recent FDA approvals and emerging therapeutic approaches. Nurse practitioners will be provided with essential knowledge to optimize patient outcomes using the latest pharmacotherapies and gain practical insights into patient selection criteria, monitoring parameters, side effect profiles, and clinical integration strategies. This presentation will explore the shift toward precision medicine in pulmonary disease management including FDA approvals of biologics for the treatment of COPD, emerging targeted lung cancer treatments, innovative AI-designed medications for fibrosis, and novel therapies for pulmonary hypertension, idiopathic pulmonary fibrosis, and pulmonary sarcoidosis.

Throughout modern medical history, fibromyalgia (FM) has been seen as a unique pain disorder of the musculoskeletal system, a disorder of abnormal sleep processing, a centralized disorder of pain processing, a psychosomatic illness, and now researchers are proposing possibly one of a few genetically similar central pain syndromes; “high-impact chronic musculoskeletal pain conditions” or “overlapping pain syndromes”. From a clinical perspective, recent studies have explored under-recognized aspects of FM. Emerging areas such as non-invasive neuromodulation, psychedelic therapies, and the integration of technologies like virtual reality and artificial intelligence are opening new frontiers in treatment, patient care, and research. These advances underscore the multifactorial nature of FM and the need for personalized, interdisciplinary approaches. Over the past 5-10 years there has been much focus and research on fibromyalgia syndrome (FMS), and the diagnosis is much better understood now than ever before. These understandings have allowed for research into the best outcomes in treatment and a new understanding to the role of pharmaceutical therapeutics. This updated lecture will focus on what primary care and specialty clinicians need to know about the current understanding of fibromyalgia pathophysiology, criteria to make the correct diagnosis and evidence-based recommendations for pharmacological and non-pharmacological options for treatment.

Low back pain is a ubiquitous complaint in primary care, posing significant challenges for patients and healthcare providers. This presentation will equip nurse practitioners with the essential knowledge and skills to confidently assess, diagnose, and manage patients presenting with acute and chronic back pain. I will delve into the nuanced differentiation of various etiologies, emphasizing critical red flag identification to ensure timely and appropriate interventions. Furthermore, the presentation will provide an evidence-based framework for developing individualized management plans, encompassing a spectrum of pharmacological and non-pharmacological strategies. Finally, we will discuss judicious use of diagnostic imaging and appropriate referral pathways, empowering nurse practitioners to optimize patient outcomes while promoting efficient healthcare resource utilization.

In this dynamic session, we’ll explore how foundational genetics and genomics are transforming everyday primary care. From decoding family history to navigating pharmacogenomics, attendees will learn practical, evidence-based strategies to personalize care, reduce risk, and improve outcomes. Using real-world cases and accessible tools, this session makes “genes-to-jeans” genomics both relevant and actionable—because your stethoscope isn’t complete without it.

The use of testosterone therapy in men has increased significantly over the past 3 decades, often extending beyond well-established clinical indications. This presentation critically explores the gap between evidence-based practice and the rising public demand for testosterone. Examine current data on the benefits and risks of testosterone therapy, including its cardiovascular and reproductive implications. It will also evaluate how media, direct-to-consumer marketing, and public perception have influenced prescribing trends in the US—particularly in men without clear medical indications. Finally, attendees will receive practical, evidence-based recommendations for the evaluation, initiation, and monitoring of testosterone therapy in clinical settings, with the goal of promoting safe, effective, and appropriate care.

Military-connected children face unique and compounding stressors that place them at increased risk for mental health concerns such as anxiety, depression, and ADHD. Despite insurance coverage through TRICARE, families often encounter barriers to accessing timely, effective, and culturally competent mental health care—particularly in rural areas and within the Military Health System (MHS). This session will examine the scope of pediatric mental health needs in military populations, highlight systemic challenges, and present practical, evidence-informed solutions. Attendees will explore models for integrating mental health services into primary care, including embedded behavioral health and teleconsultation, and leave with actionable strategies to enhance care delivery and outcomes for military-connected children.

Primary care NPs are increasingly caring for patients receiving maintenance dialysis, yet many feel unprepared to address their unique needs outside the dialysis clinic. This session will equip NPs with practical, evidence-based approaches to confidently care for dialysis patients within primary care while collaborating effectively with nephrology teams. Participants will learn what they need to know about dialysis modalities, vascular access, infection risk, and complications that commonly affect dialysis patients. The session will also address managing hypertension, volume status, anemia, mineral and bone disorders, electrolyte abnormalities, metabolic acidosis, and renal drug dosing, ensuring safe and comprehensive care for these complex patients.

Tuberculosis (TB) is an ongoing epidemic in the United States and internationally in certain countries. While rates were declining, since COVID, these rates have begun to rise again. According to the Centers for Disease, an estimated 13 million people in the United States have latent TB (LTBI) in which about 5-10% will develop TB disease over their lifetime if not treated. Primary care nurse practitioners play a key role in controlling and eliminating TB disease by treating LTBI. Non-US born recruits from high-risk countries or of high-risk environments place other recruits at risk if LTBI is not treated and progresses to actual TB disease. Military recruits live and train in close quarters, which makes screening of the upmost importance. This presentation will discuss TB disease and LTBI, screening and treatment protocols in the general population and military, and role of the nurse practitioner on the multidisciplinary team.

Evidence supports a strong, bi-directional relationship between sleep and obesity. Therefore, it is important for nurse practitioners (NPs) to assess and address disruptive sleep when providing holistic care for patients with or at risk for the chronic disease of obesity and other chronic diseases. This presentation will review the intersection between disrupted sleep and obesity and other chronic diseases, assessment of sleep throughout the life span, and interventions to address disrupted sleep. Emphasis will be placed on cultural influences of sleep habits, conditions, and interventions throughout the presentation. We will also consider interventions for disrupted sleep that promote obesity and review alternatives that are less obesogenic. By enhancing the holistic care that NPs provide to patients through assessment and treatment of risk factors contributing to obesity and other chronic diseases, we can continue to provide excellent patient-centered care and continue to increase the value of NPs in healthcare.

This presentation will cover one of the most common endocrinopathies affecting women of childbearing age: polycystic ovary syndrome or PCOS. This presentation will discuss the complex and multifactorial pathophysiology of PCOS. We will discuss the differential diagnoses, and the clinical presentation of PCOS with a special emphasis on the Rotterdam criteria for the diagnosis of PCOS. Testing and management of common comorbidities of PCOS will be explored. Treatment modalities, including pharmacological, nonpharmacological, and emerging approaches, will be discussed. Special emphasis will be placed on lifestyle recommendations for the prevention and management of PCOS.

There is a growing call for trauma-informed care, but implementing this into practice within a time-limited office visit can feel overwhelming and impractical. However, with an increasing awareness of the impact of suffering and adverse experiences on health and the important care gap NPs are bridging to provide care for marginalized and diverse patients and families, it can be one of the most important tools for an accurate diagnosis and appropriate care. This presentation will explore the evidence and need for trauma-informed care, break down the steps to building patient-provider trust through establishing rapport, and the power of informed consent for all patients in all settings in order to restore the power balance. Additionally, this session will delve into the differences of cultural competence and cultural humility in the exam room and why it matters. A patient’s trauma and diversity may not be visible, which only stresses the importance of a carefully nuanced, humble, and universal trauma-informed approach to provide effective, compassionate healthcare for all patients.

It is estimated that 1.6 million in the U.S. identify as transgender. Transgender stigma limits access to resources in healthcare, persistently affecting the physical and mental health of transgender people. The goal of this engaging lecture is to provide the tools for health care providers to better serve their transgender patients. As a foundation, the terms and concepts associated with gender will be outlined. Next, the specific risk factors that contribute to poor health outcomes in transgender patients will be explored. Common primary care and mental health care conditions in this population will be expounded upon. Finally, the benefits and risks of hormone therapy and gender reassignment surgery will be discussed.

Infectious diseases are a constant threat to the communities served by NPs. New infections are constantly emerging, and older infections once thought to be eliminated from the community are re-emerging. This fast-paced evidence-based presentation will review infections identified by the public health community that pose the highest risk in the current climate using a case study format. Newly identified infections and the resurgence of previously controlled or eliminated infectious diseases which are a significant threat to the communities served by NPs will be noted along with the description of diagnostic tools. NPs will learn which infectious diseases are on the horizon and pose the greatest risks, be able to differentiate between and accurately diagnose these infectious diseases and offer treatments where available. Currently available existing tools for prevention will be included, especially for high-risk groups.

This presentation will cover contraception management – a very important topic in women’s health. We will discuss the current trends and rates of contraception and pregnancy in the U.S. After providing a brief overview of the physiology of menstrual cycles, we will discuss the role of hormones in menstruation and reproduction to get a baseline understanding of how different contraceptive methods work. We will discuss various contraception options available in the U.S, including nonhormonal and hormonal methods and also the emerging options, including the indications, contraindications, and evidence-based guidelines for contraceptive prescription. Through case-based examples, we will explore the CDC’s medical eligibility criteria (MEC) and the U.S. selected practice recommendations (SPR) for contraceptive use and provide resources for future reference.

Chest pain is a frequent complaint in pediatric primary care and emergency settings, ranking just behind abdominal pain and headaches. While often benign or chronic in nature, chest pain in children can still be a source of anxiety for providers—especially given the fear of missing a rare but serious cardiac condition. Fortunately, studies show that cardiac causes account for less than 1% of pediatric chest pain cases. This session will provide Nurse Practitioners with a practical, evidence-based approach to evaluating chest pain in children and adolescents. Attendees will learn how to identify red flags through a focused history, physical examination, and review of systems. The session will outline a clear differential diagnosis, including musculoskeletal, pulmonary, gastrointestinal, and psychogenic causes, as well as the uncommon but critical cardiac etiologies. Case studies will illustrate real-world application, and heart sounds and basic EKG interpretation tips will be included to support clinical decision-making in outpatient settings. Whether you're in primary care or specialty practice, this session will help you build confidence in assessing pediatric chest pain, know when to reassure, when to refer, and when to worry.

Infection can be the patient's reason for admission OR a complication occurring during a hospitalization for another illness or surgery. This session will provide the participant with knowledge necessary for the effective use of antibiotics in the inpatient setting. A heavy emphasis on evidence-based practice (EBP) and clinical application will be the foundation of this session. An overview of common infections and appropriate treatment will be described, with recommendations for antibiotic choice as well as length of treatment according to the best evidence and guidelines currently available. Discussion of effective prescribing of antibiotics, interactions, and pharmacokinetic principles in the acutely ill patient will be described.

Nurse Practitioners (NPs) contribute to promoting individualized care for patients in many ways, including providing high value care. Evaluating the impact of nurse practitioner (NP) practice has become a priority area of focus for demonstrating outcomes. However, NPs often report difficulty establishing impact. A number of quality measures are available to enable practice specific evaluation of NP roles and initiatives. Various resources, toolkits and initiatives further support the efforts to evaluate NP practice quality and patient care. The imperative to demonstrate high value care in NP practice will only increase as NPs become the provider of choice for patients in all practice settings. This session will highlight strategies for demonstrating impact of the NP role using examples from NP-led initiatives and engage the audience in discussion.

This session will highlight the latest advances in lifestyle and pharmacologic therapies and how to incorporate them into a comprehensive treatment plan. You will learn how to shift from a weight-centric focus to one that is health-centric. Without proper management, weight reduction from high potency obesity medications and bariatric procedures may pose serious health risks that may worsen over time. You will learn evidence-based strategies that reduce adiposity, preserve lean body mass, and optimize health.

The objective is to evaluate pediatric trauma, pediatric lower extremity injuries. Children’s musculoskeletal problems are different than those of an adult. As children develop and grow, their body responds to injuries, infection, or deformity differently from an adult. The aims of this presentation are to enhance nurse practitioners' knowledge to obtain health histories, perform comprehensive physical examinations, including psychosocial, functional, and development assessment, develop differential diagnoses, treat, and manage pediatric fractures immediately. Review of the most commonly seen in the emergency department included but not limited to Slipped Capital Femoral Epiphysis (SCFE), pelvic avulsion fractures, femoral shaft fractures, tibial tubercle fractures, tibial spine fractures, Toddler’s fracture/spiral tibial shaft fracture, tibia and/or fibular fracture, patellar sleeve fractures, ankle and foot fractures,. Multidisciplinary team care of pediatric orthopedic fracture patients is essential. Emphasis on a collaborative approach with nurse practitioners, nurses, orthopedic surgeons, radiologists, social workers, physical and occupational therapists will be reviewed through case-based learning.

This presentation provides a comprehensive overview of the latest advancements in diabetes management, clinical therapies, and emerging technologies. Key topics include new indications and pharmacological agents for the treatment of diabetes and its related complications and comorbidities, combination therapy strategies, and the role personalized medicine and pharmacogenomics. This session will explore cutting-edge technological innovations such as updated continuous glucose monitoring devices, next-generation insulin pumps, wearable devices, mobile health applications, and remote monitoring solutions. Attendees will gain insights into future directions and ongoing research shaping the field, equipping nurse practitioners with the knowledge to improve patient outcomes in an evolving landscape.

Artificial intelligence (AI) is rapidly transforming many industries; however, its adoption in healthcare remains cautious due to concerns about diagnostic accuracy, patient privacy, and data security. However, nurse practitioners (NPs) must embrace AI to stay competitive and deliver safe, efficient patient care. Research shows AI can significantly reduce administrative and repetitive tasks, streamline data management, and improve diagnostic efficiency. This not only enhances clinicians’ job satisfaction but also frees NPs to spend more focused time with patients, improving outcomes through more accurate information and timely interventions. To successfully integrate AI, nurse practitioners must be aware of the available tools and know how to utilize them effectively. In this session, I will introduce practical AI tools for use in clinical practice. Attendees will gain hands-on experience and actionable strategies to reduce workload, enhance documentation, support clinical decision-making, and improve patient care, while understanding the ethical and legal considerations essential for safe AI use.

In this one-hour session, we will take a candid look at what it's like to be an NP working in a prison. We will explore a typical day—from intake assessments and sick-call triage to running chronic care clinics and coordinating closely with custody staff. We will dive into the unique health risks of this high-risk population, where rates of mental illness, chronic disease, infectious outbreaks, and substance use are far higher than in the general public. Participants will also learn how NP practice is shaped by security protocols and limited resources. And we’ll tackle the tough ethical issues—understanding how Estelle v. Gamble enshrines inmates’ right to healthcare, navigating the dual-loyalty conflicts that come with caring for incarcerated patients, and exploring how CCHP certification supports autonomous, high-quality practice. By the end, participants will come away with a grounded sense of what correctional NPs do, why the work is challenging yet deeply meaningful, and how to begin pursuing this important career path.

Depression, or major depressive disorder, in men is often underdiagnosed due to gender-specific presentations and societal stigma surrounding emotional vulnerability. This presentation will explore how nurse practitioners can improve the detection of depression in male patients by using screening tools adapted for men, such as the Gotland Male Depression Scale, and by recognizing externalizing symptoms like irritability, risk-taking, anger, and substance misuse. Cultural barriers, including traditional masculine norms that discourage the disclosure of emotions, will be discussed to help providers create safe spaces for open dialogue. Nurse practitioners play a critical role in early identification, intervention, and the delivery of holistic, patient-centered care that addresses both psychological and physical health. Practical strategies to engage men in conversations about mental well-being and connect them with appropriate resources will be shared. Attendees will leave with actionable steps to enhance their practice and improve mental health outcomes for male patients.

This session provides an evidence-based overview of pharmacologic treatment options for managing obesity in adults. With obesity rates rising and treatment standards evolving, nurse practitioners must stay informed about available medications. This presentation will review mechanisms of action, indications, safety profiles, and prescribing considerations for current FDA-approved anti-obesity agents, including GLP-1 receptor agonists, combination therapies and alternatives. Clinically relevant data will be discussed to support decision-making in everyday practice. Through case-based examples, participants will apply knowledge to patient scenarios involving medication selection, monitoring, and long-term treatment planning. Special attention will be given to managing obesity in older adults and individuals with cardiovascular risk factors or metabolic syndrome. By the end of this session, nurse practitioners will be equipped to integrate pharmacologic interventions into individualized, guideline-informed care plans that improve outcomes across diverse patient populations.

More than 1 in 7 adults in the United States has chronic kidney disease (CKD) and many people do not know they have it. Many patients are first identified as having CKD by their primary care providers, but screening and diagnosis is still underutilized in this setting. Nurse practitioners (NPs) are key members of primary care teams and help lead the translation of evidence into practice across care settings. This presentation will provide nurse practitioners working in primary care environments with a comprehensive overview of current guidelines and strategies for screening, identification, and management of CKD. We will focus on identifying and slowing the progression of CKD to end-stage renal disease (ESRD) through the implementation of evidence-based guidelines for lifestyle modification, guideline-directed medical therapy, adoption of clinical decision support tools, and communication and collaboration with the multi-disciplinary team. This presentation will also highlight the intersection of multi-complexity among this patient population.

Immunizations are the number one Public Health Achievement for the 20th century. Recently there have been challenges to the annual evidence-based CDC immunization schedules. To fill this void the American Academy of Pediatrics (AAP) and the Vaccine Integrity Project from the Center for Infectious Diseases Research and Policy (CIDRAP) of the University of Minnesota will issue 2026 immunization schedules for children, adolescents, and adults using the best available evidence. This fast-paced presentation using a case study format will review the latest evidence-based changes to the schedules. Vaccine hesitancy will also be reviewed and will offer paradigms that offer tools to address this ever-growing problem. New and emerging vaccines will also be discussed. Resources to keep current with the best available evidence for immunization practice will also be shared.

“I’m Not a Jerk: Living with RLS” explores the clinical and personal impact of Restless Legs Syndrome (RLS), a frequently misunderstood neurological disorder. This session provides a comprehensive overview of RLS, including its pathophysiology, diagnostic criteria, and significant effects on sleep, mental health, and daily functioning. Emphasis is placed on identifying secondary causes, evaluating iron status, and avoiding common pharmacologic pitfalls such as dopamine agonist-induced augmentation. Evidence-based management strategies are reviewed, highlighting non-pharmacologic interventions, iron supplementation, and the use of alpha-2-delta ligands. Special considerations for children and pregnant patients are addressed. The talk also underscores the nurse practitioner’s role in early recognition, patient education, and long-term management. Through a blend of clinical evidence and patient-centered insights, this presentation aims to equip providers with practical tools to improve outcomes and quality of life for individuals living with RLS.

It is estimated that more than 1 in 5 adults is living with mental illness in the U.S. Most psychotropic medications are being prescribed and monitored in the primary care setting (Hughes et at., 2024). Many psychotropic medications require specific monitoring. Current monitoring practices in primary care are not meeting recommended guidelines (Baldacci et al. 2023). This program will educate participants on pertinent monitoring recommendations for common psychotropic medications to increase safe prescribing practices. Antidepressant classes require different types of screening and monitoring as possible side effects can vary. In the case of second-generation antipsychotics (SGA’s), there are multiple guidelines to review (Ali et al., 2021). Cardiometabolic side effects of SGA’s can have a significant impact on patient health outcomes (Ali et al., 2021). Monitoring weight, fasting glucose, and lipids are minimum standards for safe practice. Some psychotropic medications such as lithium and valproic acid require monitoring of drug concentration levels. Therapeutic drug monitoring (TDM) helps to optimize individual outcomes through comparison of individual drug concentration levels to reference ranges (Hart et al., 2021). Education on psychotropic medication monitoring in primary care is essential to providing safe care to patients with mental illness (Ayre et al., 2023).

The session will begin with a description of the most common scenarios in which ethical conflict occurs. We will explore biomedical ethics concepts including autonomy, beneficence, non-maleficence, and justice. The evolving definitions of medical futility, nonbeneficial therapies, and the withholding of potentially inappropriate therapies will be discussed from a medical, legal, and ethical perspective, integrating current research and recent practice recommendations from professional associations. The application of core ethical principles to the real-world care of acutely ill patients and a framework for analysis of complex cases will be described. The facilitator will clearly outline a process for evaluating clinical cases for ethical conflict or the potential for improving the ethics of a case. Moral distress, its’ effect on nurses, and strategies to mitigate it are explored. This session will be applicable to all practice settings and specialties.

Pediatric musculoskeletal complaints are common in primary care and often represent benign developmental variants. However, timely recognition of pathologic conditions is essential to prevent long-term complications. This presentation reviews frequently encountered issues such as intoeing, bowed legs, knock knees, pes planus, Osgood-Schlatter disease, developmental dysplasia of the hip (DDH), slipped capital femoral epiphysis (SCFE), scoliosis, and pediatric limping. Emphasis is placed on distinguishing normal from abnormal findings, identifying red flags, and determining appropriate management or referral. Practical strategies for screening, diagnosis, and anticipatory guidance are discussed, along with visual aids and age-based clinical tools. This session aims to enhance clinical confidence in evaluating musculoskeletal presentations and promote early detection of serious conditions such as SCFE, septic arthritis, or DDH.

This session will explore the dynamic field of pharmacogenomics and its role in personalizing medication to enhance patient outcomes. Participants will examine how genetic variations in drug metabolism impact prescribing practices and therapeutic decisions. Real-world case studies will illustrate how pharmacogenomic testing can optimize pharmacotherapy for patients across the lifespan. By the conclusion of the session, APRNs will be equipped with practical tools to incorporate pharmacogenomic principles into their clinical practice, thereby improving patient care and minimizing adverse drug reactions.

Peripheral Artery Disease (PAD) affects over 200 million individuals worldwide and is a leading cause of morbidity and mortality due to its association with major cardiovascular events and limb ischemia. As diagnostic technologies evolve and new evidence emerges from clinical trials, timely updates to clinical practice guidelines are critical to optimizing patient outcomes. This presentation will highlight the key revisions in the latest PAD guideline update, focusing on screening and diagnosis, medical therapy, revascularization strategies, and risk factor modification.

Substance use disorders (SUDs) remain a critical public health concern and a leading driver of preventable morbidity and mortality in the United States. Primary care nurse practitioners (NPs) are uniquely positioned to engage patients early and deliver ongoing support. However, many NPs express uncertainty about how to care for individuals with SUDs, particularly when abstinence is not the immediate goal. This session provides an actionable framework for integrating harm reduction into everyday clinical practice. Harm reduction is an evidence-based, compassionate approach that focuses on minimizing the negative consequences of substance use without requiring abstinence. Grounded in principles such as humanism, autonomy, pragmatism, and incremental change, harm reduction offers a patient-centered path to care. This session will equip NPs to navigate real-world barriers such as provider discomfort and institutional resistance, and provide strategies for communicating with patients using supportive, non-stigmatizing language. NPs will leave this presentation with renewed confidence, clear tools, and an understanding of how to deliver whole-person, evidence-based care to patients with SUDs using harm reduction principles. Medications for opioid, tobacco, and alcohol use disorders, including initiation and dosing will be addressed as one element of a comprehensive approach to person centered care for individuals who use drugs.

We will focus on the 2022 AHA/ACC/HFSA Heart Failure Guidelines. I will also include information on the 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment. Using the guidelines and consensus document, we will discuss initiation and titration of medications. We will also discuss strategies for dealing with complex cases, and how and when to use BNP and NP-proBNP biomarkers.

"Opioid Management in Cancer Patients: Balancing Efficacy, Safety, and Stewardship” Pain is one of the most common and distressing symptoms in cancer patients, and opioids remain a cornerstone in cancer pain management. However, the current opioid crisis and regulatory pressures have created a complex landscape for prescribers. This session will explore evidence-based strategies for opioid use in cancer care, focusing on patient safety, regulatory compliance, and individualized treatment planning. Through case-based discussions and guideline updates, attendees will learn how to initiate, titrate, and monitor opioid therapy in cancer patients while mitigating risks of misuse, dependence, and under-treatment of pain. The session will also address management of opioid-induced side effects and integrating non-opioid and non-pharmacologic approaches.

The Centers for Medicare and Medicaid Services (CMS) introduced the Age-Friendly Hospital Measure for fiscal year 2025, designed to enhance the healthcare experience for elderly patients. A comprehensive geriatric postoperative program equips institutions with the essential support needed to meet CMS standards by ensuring the adoption of evidence-based protocols and processes that enhance hospital efficiency and improve patient outcomes. This presentation seeks to outline the evidence-based protocols and processes that enhance postoperative surgical care and outcomes for older adults by promoting a patient- and family-centered approach. Advanced Practice Registered Nurses (APRNs) play a crucial role in the care of hospitalized patients, frequently overseeing complex geriatric postoperative cases. APRNs must stay informed about the latest evidence-based, age-friendly practices to enhance their expertise, refine their skills, comply with the CMS Age-Friendly Hospital Measure, and ultimately deliver the highest quality of care.

Difficult conversations are a routine part of clinical practice, including in pain medicine. Learning the "art" of communication and how to approach difficult conversations as it pertains to pain management takes time and practice. The goal of this presentation is to provide guidance and support in how to manage difficult conversations in different pain management scenarios.

Introduction: This quality improvement project aimed to address high turnover rates among novice nurse practitioners in the emergency department, attributable to low job satisfaction. Dissatisfaction among nurse practitioner staff is linked to decreased engagement, productivity, and suboptimal patient outcomes and negatively affects both novice and seasoned staff morale. Low job satisfaction correlates with higher turnover rates, increased departmental costs, and a decline in the overall quality of patient care. Outcomes from this project confirmed that mentoring positively affects job satisfaction and the transition of novice nurse practitioners. Methods: Conducted in a large urban academic medical center, this project involved 7 novice nurse practitioner participants. Inspired by the National Association of Neonatal Nurse Practitioners Mentoring Toolkit, a 10-week Knowledge to Action Framework structured mentorship program was devised. It included an introductory session, individual mentor-protégé meetings, and a wrap-up session. Pre- and postintervention evaluations used the Misener Nurse Practitioner Job Satisfaction Scale. Results: Preintervention Misener Nurse Practitioner Job Satisfaction Scale scores averaged 176.3, increasing to 206.4 after the intervention, with a statistically significant improvement (T = -1.82; P = .046). Discussion: Mentorship programs offer significant benefits to nurse practitioners, contributing to improved clinical practice and more efficient health care systems by improving job satisfaction, reducing turnover rates, enhancing patient outcomes, and curbing costs. However, further research is needed to establish definitive evidence of their long-term impact. Key words: Mentor program; Job satisfaction; Role transition; Turnover

Ethical dilemmas are an inevitable part of healthcare practice, arising when clinical decisions intersect with patient values, professional responsibilities, and institutional or societal constraints. These situations challenge NPs to make difficult choices while upholding the core principles of medical ethics: autonomy, beneficence, non-maleficence, and justice. This presentation will examine common ethical dilemmas faced in today’s healthcare settings, from end-of-life care and informed consent to cultural considerations. Through the use of case examples and discussion, participants will explore practical strategies for applying ethical frameworks to real-world situations, fostering collaborative decision-making, and maintaining integrity in complex clinical environments. Attendees will leave with a clearer understanding of how to approach ethical challenges with confidence, compassion, and professional accountability

Immunizations are recognized as one of the most impactful public health interventions in history. This presentation traces the evolution of vaccine science, from early practices to the development of cutting-edge mRNA technology. By examining historical milestones and the public health challenges of the past, we will uncover crucial lessons for navigating today’s complex landscape. By exploring historical vaccination campaigns, ethical considerations, and past obstacles that mirror current challenges, we will show how these experiences can inform modern strategies for global immunization. Looking ahead, we will discuss strategies for addressing vaccine hesitancy and medical misinformation and the path toward ensuring equitable access to vaccines for all. Attendees will leave with a deep understanding of the scientific breakthroughs, historical context, and societal factors that have shaped vaccine development and implementation.

Sleep disturbances and cancer-related cognitive impairment (“chemo brain”) are among the most common and persistent challenges faced by cancer survivors, yet they are often overlooked in survivorship care. This session explores the physiological role of sleep—particularly REM and NREM stages—in immune regulation, emotional processing, and memory consolidation, and how cancer treatments disrupt these restorative processes. Participants will learn to apply both pharmacological and non-pharmacological strategies, including CBT-I, sleep hygiene education, and cognitive rehabilitation techniques.

Obsessive-compulsive disorder (OCD) is a complex and often misunderstood condition that can significantly impact a patient’s quality of life if not properly identified and treated. For psychiatric-mental health nurse practitioners (PMHNPs), recognizing the nuanced presentation of OCD is essential to providing timely, evidence-based care. This presentation will equip PMHNPs with the knowledge and tools to effectively identify and manage OCD across diverse clinical settings. Attendees will learn practical strategies for screening and differentiating OCD from other psychiatric conditions, ensuring accurate diagnosis and early intervention. The session will also provide a comprehensive review of current pharmacological treatments, including first-line options, augmentation strategies, and considerations for treatment-resistant cases. Beyond medication management, participants will explore evidence-based non-pharmacological interventions, such as cognitive-behavioral therapy with exposure and response prevention (ERP), mindfulness-based approaches, and the integration of these therapies into collaborative treatment plans. By the end of this presentation, PMHNPs will have enhanced confidence in identifying OCD, tailoring pharmacologic regimens, and incorporating psychotherapeutic strategies to support recovery. With a focus on practical application, this session emphasizes a holistic, patient-centered approach that empowers providers to break the cycle of obsessions and compulsions while improving long-term outcomes.

Stigma is a well-documented challenge for patients with Ehlers-Danlos syndromes (EDS), especially in the context of chronic pain. Many report feeling dismissed, misunderstood, or not believed by healthcare professionals—a problem compounded by underdiagnosis, limited awareness, and the often-invisible nature of symptoms. Delayed diagnosis and the complexity of pain presentations frequently lead to frustration, psychological distress, and barriers to care. This presentation will review common symptom patterns and diagnostic criteria for these frequently overlooked, yet very real, syndromes. EDS are heritable connective tissue disorders in which chronic pain is highly prevalent and multifactorial. For nurse practitioners, clinical assessment should include identifying pain subtypes: nociceptive (joint instability, subluxations, soft tissue injury), neuropathic (peripheral nerve involvement), and central sensitization (widespread pain, fatigue, sleep disturbance). Screening for comorbidities such as anxiety, depression, and autonomic dysfunction is equally critical, as these factors often intensify pain and disability. Although the clinical picture is complex, adopting a holistic and patient-centered approach allows nurse practitioners to validate patients’ experiences, reduce stigma, and provide evidence-based care. By addressing both physical and psychosocial factors, NPs can help minimize the impact of EDS and improve patients’ quality of life.

Nurse Practitioners (NPs) are more than healthcare providers—they are trusted community leaders and civic stewards. This session explores how NPs can actively defend the pillars of democracy by integrating practical strategies in their professional roles, within nursing and non-nursing organizations, through local community volunteerism and broader policy engagement. Democracy thrives when healthcare professionals actively defend its principles, and NPs stand at the intersection of health, equity, and civic responsibility, making their voices indispensable. By executing their duties as democracy defenders, NPs ensure not only the well-being of the global patient population but also the integrity of the systems that shape their lives. As nurse practitioners and members of the nursing profession, we are ethically obligated to utilize our scientific, biologically grounded, evidence-based education and skill set to identify and facilitate solutions across various domains—both within and beyond healthcare. This on-demand session will provide a solid foundation for working efficiently and effectively in concert to study and disseminate quality improvement processes that align with the Code of Ethics for Nurses, through activism that mitigates social and structural determinants of health.

Incretin medications are becoming increasingly popular, with 1 in 8 individuals reporting their use. As the indications for these medications continue to expand, access is expected to increase. Despite the many benefits of these medications, side effects often lead to discontinuation. This presentation explores essential nutrition considerations for individuals taking incretin medications, aiming to enhance treatment outcomes and minimize adverse effects. Learn about optimal dietary approaches, potential nutrient deficiencies, and strategies for addressing common gastrointestinal side effects to ensure a safe and effective treatment journey for your patients.

Across the United States, nurse practitioners are increasingly being confronted with scarce healthcare resources which include provider shortages, insurance barriers, and limited specialty services in rural and underserved areas. At the same time, the burden of chronic illness continues to rise, with patients and families needing complex support long before the end of life. Currently, specialty palliative care resources are stretched thin, leaving a gap that nurse practitioners in all practice settings must help to fill. This presentation will equip advance practice nurses with primary palliative care skills—including core symptom management, serious illness communication, and care coordination—that can be implemented in everyday practice. Drawing on current guidelines and evidence-based strategies, this session will emphasize practical, scalable approaches to providing whole-person care in environments where resources are limited but the need is great.

Digital twins are virtual, dynamic replicas of patients that integrate data from electronic health records, wearable sensors, imaging, and genomics into a continuously updated model of health. Unlike traditional patient-generated data from apps or devices, which provide only discrete measures such as blood pressure or step count, digital twins simulate the whole patient by combining multiple inputs into a real-time, adaptable representation. This allows clinicians to model disease progression, predict treatment responses, and test “what-if” scenarios before making care decisions. For nurse practitioners, this technology holds particular promise in chronic disease management, precision medicine, and preventive care, where tailoring interventions can significantly improve outcomes. While routine outpatient use remains in early stages, pilot programs show benefits in reducing hospital readmissions, supporting personalized treatment plans, and enhancing patient engagement. At the same time, digital twins introduce challenges related to ethical use, patient privacy, data security, and equitable access. Nurse practitioners, as both direct care providers and clinical leaders, are well positioned to shape how this technology is adopted, ensuring that it enhances rather than complicates patient care. This session will provide practical insights into applications, challenges, and opportunities of digital twins in everyday NP practice.

Telehealth continues to evolve rapidly offering opportunities for reshaping the delivery of healthcare into a model that is increasingly predictive, personalized, and data-driven. For nurse practitioners (NPs), these advances offer new opportunities to expand access, improve outcomes, and enhance efficiency in patient care. Innovations such as generative and agentic artificial intelligence (AI), ambient listening, and digital therapeutics (DTx) are redefining virtual care by streamlining documentation, enabling real-time risk detection, and delivering evidence-based interventions across diverse settings. Telehealth platforms extend care delivery strategies including nutrition support, direct-to-consumer models, and even workforce solutions that extend opportunities for equitable care delivery. While these innovations seek to expand individualized care, these advances are tempered by persistent challenges. Federal telehealth policy remains uncertain, state regulations vary widely, and reimbursement models lack equity and predictability. This policy instability threatens both innovation and sustainable access, especially in rural and vulnerable populations. Nurse practitioners stand at the forefront of this evolving landscape, uniquely positioned to leverage emerging technologies while advocating for equitable, stable, and patient-centered frameworks. This session will examine the latest telehealth innovations, identify pressing policy and funding barriers, and provide strategies for NPs to lead in balancing innovation, equity, and sustainability in evolving telehealth practice.

For decades, Emergency Nurse Practitioners have played a vital role in advancing the safety, quality, and efficiency of emergency care across both traditional and nontraditional settings. Despite record growth in the number of nurse practitioners reporting employment in emergency care settings, the profession continues to face significant workforce, workplace, regulatory and practice-related challenges. Rising patient acuity, growing expectations, staffing shortages, emergency department overcrowding and boarding, and increasing workplace violence challenges even the most resilient providers. Despite these demands, ENPs remain committed to delivering exceptional care, often choosing this demanding practice environment despite its pressures. This panel will bring together experienced ENPs for a dynamic discussion exploring the current landscape of ENP practice. Panelists will highlight obstacles and opportunities, sharing actionable insights and strategic perspectives to address barriers, and enhance well-being and job satisfaction, to further elevate the future of ENP practice.

Untreated blood stream bacterial (BSI) infections can be a risk factor for developing life threatening conditions such as sepsis, endocarditis, meningitis. To decrease mortality and morbidity from blood stream infections, it is important that nurse practitioners working in acute care are able to recognize, evaluate and treat these infections. Using a case study approach, a variety of infectious disease will be presented along with interpretation of various tests including, but not limited to cultures, spinal fluid analysis, procalcitonin and physical findings.

Practitioners are challenged to appropriately identify and treat various types of staphylococcal infections, such as community acquired versus hospital acquired methicillin infections vs methicillin sensitive and other staph infections. Some of these staphylococcal infections can be life-threatening, thus appropriate antibiotic use is essential. Knowing which type of antibiotics are effective, contraindicated, bactericidal, and bacteriostatic in various conditions is essential to all practitioners caring for these patients.

Immune checkpoint inhibitors have revolutionized cancer management by targeting the regulators of the immune system, specifically CTLA-4, PD-L1, and PD-1, and are used to treat various cancers. While patients with cancer on the ICI treatment, the immune-related adverse events (irAEs) can develop any time after initiation of the treatment. The toxicities can affect any organ or system of the body, ranging from mild to severe forms of toxicity, and can lead to life-threatening events. GI toxicities are one of the most common toxicities, and they can affect the quality of life of patients. As the number of cancer patients and cancer survivors increases, primary care clinicians and hospital medicine clinicians are involved in these patients' care not only in the early diagnostic stage, but also during follow-up while the patient is on active immunotherapy. Early recognition of symptoms is critical to initiate timely, organ-specific, and severity-guided management, which is essential for minimizing complications and optimizing patient outcomes.

Chronic pelvic pain (CPP) is a complex, often misunderstood and undertreated condition affecting up to 25% of women worldwide. This session will equip clinicians with a practical, multimodal framework for evaluating and managing CPP in primary care and gynecology-focused settings. Attendees will learn to identify key pain mechanisms, including nociceptive, neuropathic, and nociplastic pain. They will be able to perform trauma-informed assessments, and gain the confidence to align treatment plans with individual patient needs. The presentation integrates evidence-based strategies for managing chronic overlapping pain conditions (COPCs), central sensitization, and pelvic floor dysfunction. Participants will leave with tools to provide compassionate, mechanism-informed care that improves outcomes and restores function, as well as resources for how/where to refer patients when necessary.